期刊文献+

关于吴茱萸商品规格的探讨 被引量:1

Discussion on commodity specifications of Euodiae Fructus
下载PDF
导出
摘要 本文对吴茱萸商品规格研究进展进行了系统梳理,并探讨吴茱萸商品规格与品种、采收期和混伪品的相关性,同时调研考察吴茱萸药材市场及产地现状。文献梳理及产地调研发现,吴茱萸的商品规格与基原、采收期和混伪品密切相关。目前市场上大、中、小花吴茱萸主要是由于吴茱萸不同成熟期和不同品种导致的果实大小不一以及混伪品充当吴茱萸使用所致。此外,市场等级划分不统一,处于自发分级的状态。客观分析吴茱萸商品规格研究进展,结合产地调查结果,应基于药典中规定的药材大小和柠檬苦素、吴茱萸碱及吴茱萸次碱的含量,对市场上的吴茱萸进行严格把控,确保吴茱萸临床应用的安全性和有效性。 The research progress of the commodity specifications of Euodiae Fructus(EF)and its correlation with varieties,harvest time and adulterants were systematically reviewed and discussed in this paper.The current situation of the market and production areas of EF were also investigated.The commodity specifications of EF were found to be closely related to the varieties,harvest time and adulterants basing on literature and production areas research findings.At present,EF was divided into small flower EF(SEF)group,medium flower EF(MEF)group,and big flower EF(BEF)group in the market,which was mainly due to the different fruit sizes caused by different mature periods,the different varieties and adulterants of EF.In addition,the market grading of EF was not uniform and in a state of spontaneous grading.According to the objective analysis on the research progress of commercial specifications of EF and in combination with the investigation results of the production areas,the EF in the market should be strictly controlled based on the size and contents of limonin,evodiamine as well as rutaecarpine of EF according to Pharmacopoeia so as to ensure the safety and effectiveness of clinical application of EF.
作者 张薇 张天骥 康强 任昆 王维宁 曲寿河 潘英妮 刘晓秋 ZHANG Wei;ZHANG Tianji;KANG Qiang;REN Kun;WANG Weining;QU Shouhe;PAN Yingni;LIU Xiaoqiu(School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical University,Shenyang 110016,China;Liaoning Institute for Drug Control,Shenyang 1100366,China)
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2023年第8期1092-1097,1132,共7页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金项目(81773879) 辽宁省高等学校国(境)外培养项目(2018LNGXGJWPY-YB024) 国家中医药管理局全国中药特色技术传承人才培训项目(国中医药人教函[2019]43号)。
关键词 吴茱萸 商品规格 采收期 品种 混伪品 Euodiae Fructus commodity specification harvest time variety adulterants
  • 相关文献

参考文献9

二级参考文献102

  • 1许建成,楚英华,王艳丽.中药敷脐治疗小儿慢性腹泻360例[J].河南中医,2004,24(8):39-39. 被引量:4
  • 2刘保林,吴巍巍,靳长峰,王音.吴茱萸次碱对小鼠溃疡性肠炎的治疗作用[J].中国临床药理学与治疗学,2004,9(11):1273-1277. 被引量:26
  • 3刘勇,崔颖鹏,宋涛,杨栋梁.吴茱萸次碱促进脑组织降钙素基因相关肽释放减轻脑缺血-再灌注损伤[J].中国医师杂志,2005,7(5):589-591. 被引量:9
  • 4Florean C, Schnekenburger M, Grandjenette C, et al. Epigenomics of leukemia: from mechanisms to therapeutic applications [J]. Epigenomics, 2011, 3(5): 581-609.
  • 5Carew J S, Giles F J, Nawrocki S T. Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy [J]. Cancer Lett, 2008, 269(1): 7-17.
  • 6Barneda-Zahonero B, Parra M. Histone deacetylases and cancer [J]. Mol Oncol, 2012, 6(6): 579-589.
  • 7McCubrey J A, Steelman L S, Chappell W H, et al. Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response [J]. Oncotarget, 2012, 3(9): 954-987.
  • 8Hoshino R, Tanimura S, Watanabe K, et al. Blockade of the extracellular sigr~al-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated:up-regulation of p27 (Kipl) [J]. J Biol Chem, 2001, 276(4): 2686-2692.
  • 9Kortylewski M, Heinrich P C, Kauffmann M E, et al. Mitogen-activated protein kinases control p27/Kipl expression and growth of human melanoma cells [J]. Biochem J, 2001, 357(1): 297-303.
  • 10Cory S, Huang D C, Adams J M. The Bcl-2 family: roles in cell survival and oncogenesis [J]. Oncogene, 2003, 22(53): 8590-8607.

共引文献70

同被引文献62

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部